Focusing On The Year To Date Gainers: $VG $FOLD $PAAS


The Market Signal was created as a platform to help investors, if you own (NASDAQ:VG), (NASDAQ:FOLD) or (NASDAQ:PAAS) and want to join the fastest growing community of investors on the web then sign up to the link below. Members get free access to the best investment tools in the world. Start trading like a pro today. This is a limited time offer so click the link below NOW.

https://themarketsignal.com/Free-Report/NOW
(Click link above or copy, paste and hit enter in your browser for your report)

Vonage Holdings CEO buys shares

https://themarketsignal.com/Free-Report/VG

(Click link above or copy, paste and hit enter in your browser for your report)

The year to date performance of Vonage Holdings Corp.(NASDAQ:VG) has climbed by a 52.77% margin. Rory P Read, who happens to be the CEO of Vonage Holdings Corp acquired VG shares totaling to 17,870 shares. Each of the shares was being sold at $11.29, a transaction involving g about $201,752.

CEO Recent Trades:

The CEO bought 17,870 VG shares as of 08/26/2020. Rory P Read had to pay an amount of $11.29 for each of the shares. Reports show the stock to have scaled higher by a margin of 0.27% since.

Move by the CEO to buy 16,935 shares of VG stock where each share was sold at $11.83. That is a 4.31% decrease.

CFO Recent Trades:

CFO David T. Pearson agreed to a rate of $12.25 for each share on 08/04/2020. That represents a decline in stock standing at a value of 7.59%.

CFO Recent Trades:

CFO David T. Pearson agreed to a $12.25 rate in the sale of 308,919 shares on 08/04/2020. That value was representative of a 7.59% decline.

Directors and Officers Recent Trades:

SagiDudai who happens to be the company’s Chief Technology Officer agreed to an average rate of $12 in the sale of 25,039 shares. That happened on 07/31/2020 and analysts have noted a 5.67% decrease.

Amicus Therapeutics attains impressive results

https://themarketsignal.com/Free-Report/FOLD

(Click link above or copy, paste and hit enter in your browser for your report)

Amicus Therapeutics, Inc. (NASDAQ:FOLD) on a year to date basis scaled higher by a 51.54% margin.

2020 Key Strategic Priorities

  • Achieve global product revenue for Galafold totalling to about $250 million to $260 million.
  • Making the final touches on the enrollpediatric studies to promote 2021 MAA and BLA.
  • Focussing on the CLN6 and CLN3 Batten programs, in which case the company is in discussions focussed on advance clinical development and manufacturing activities. The discussions also focus on regulatory issues.
  • The unveiling of two drug candidates and the focus on the Pompe gene therapy linked to the development of an Investigational New Drug (IND) application.
  • Uphold the company’s strong financial standing.

2020 Financial Guidance

  • Based on the 2019 exchanges rates, the company hopes to attain $250 million to $260 million of Galafold revenue.
  • The 2020 full-year Non-GAAP operating expense guidance stands at a figure of about $410 million to $420 million. Several reasons have been cited, part of those including the unveiling of the company’s gene therapy pipeline2 and continued investment in the global Galafold launch.

Pan American Silver unstoppable in the face of the COVID-19 pandemic

https://themarketsignal.com/Free-Report/PASS

(Click link above or copy, paste and hit enter in your browser for your report)

The year to date performance of Pan American Silver Corp. (NASDAQ:PAAS) scaled up by a margin of 50.78%.

Q2 2020
Revenue $249.5 million
Consolidated silver production 2.8 million ounces
Consolidated gold production 96.6 thousand ounces
CFO $62.8 million
Net income $19.4 million

The company achieved a revue amounting to $249.5 million. It witnessed impressive precious metal prices, with silver and gold playing at $16.58 and $1,708 per ounce respectively.

  • The outbreak of the COVD-19 pandemic had caused suspensions in the company’s Latin American operations, but that has been offset by the outstanding performance.
  • The deadly pandemic caused a drop in the costs of sales and revenue considering that only $48.4 million was fetched in line with the operations at the mine. The figure for the Net Income stood at $19.4 million.

Please email or contact us for any edits or errors relating to this stock market news.

If you would like information on using our press release distribution service aimed at helping investors with the best stocks to buy and how to create your own stock portfolio. We cover the US Stock Market, Canadian Stock Market, the Australian Stock Market and other Stock Market news.

We will get back to you within 24 hours.

Disclaimer

comtex tracking

COMTEX_370471467/2703/2020-09-01T07:46:31

Is there a problem with this press release? Contact the source provider Comtex at editorialpr@comtex.com.